Accurate Prostate Cancer Following Using Low-Field MRI (Low-PRISM)
Recruiting
Observational Study
Prostate Cancer
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Male
- Study type
- Observational
- Participants needed
- 74 (estimated)
- Sponsor
- University of Lausanne Hospitals · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This study compares the effectiveness of low-field MRI (0.55T) with high-field MRI (3T) in prostate cancer screening and image quality. It consists of three phases: optimizing the low-field MRI protocol with healthy volunteers, evaluating image quality in patients with metallic artifacts (like hip prostheses), and assessing low-field MRI in patients with suspicious prostate lesions found on high-f…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
Work Package1 (WP): 0.55T MRI Protocol Development
* Healthy male volunteers aged 18 and above.
* Agree to be contacted for incidental findings
* Signed informed consent
WP2: 0.55T Prostate MRI with patients with metallic implant(s)
* Adult men (≥18 y.o) with 3T MRI reported …
Contacts